Objective response rate as a surrogate end point: a commentary.
Fleming
Thomas R
TR
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D023381:Endpoint Determination; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D016019:Survival Analysis; D016896:Treatment Outcome
D014408:Biomarkers, Tumor